| First Author | Cheng X | Year | 2020 |
| Journal | Commun Biol | Volume | 3 |
| Pages | 10 | PubMed ID | 31909202 |
| Mgi Jnum | J:285960 | Mgi Id | MGI:6393463 |
| Doi | 10.1038/s42003-019-0716-8 | Citation | Cheng X, et al. (2020) NHC-gold compounds mediate immune suppression through induction of AHR-TGFbeta1 signalling in vitro and in scurfy mice. Commun Biol 3:10 |
| abstractText | Gold compounds have a long history of use as immunosuppressants, but their precise mechanism of action is not completely understood. Using our recently developed liver-on-a-chip platform we now show that gold compounds containing planar N-heterocyclic carbene (NHC) ligands are potent ligands for the aryl hydrocarbon receptor (AHR). Further studies showed that the lead compound (MC3) activates TGFbeta1 signaling and suppresses CD4(+) T-cell activation in vitro, in human and mouse T cells. Conversely, genetic knockdown or chemical inhibition of AHR activity or of TGFbeta1-SMAD-mediated signaling offsets the MC3-mediated immunosuppression. In scurfy mice, a mouse model of human immunodysregulation polyendocrinopathy enteropathy X-linked syndrome, MC3 treatment reduced autoimmune phenotypes and extended lifespan from 24 to 58 days. Our findings suggest that the immunosuppressive activity of gold compounds can be improved by introducing planar NHC ligands to activate the AHR-associated immunosuppressive pathway, thus expanding their potential clinical application for autoimmune diseases. |
